[Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy].

about

[Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy].

Item

http://www.wikidata.org/entity/Q43913506

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@en

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@nl

type

Item

label

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@en

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@nl

prefLabel

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@en

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@nl

P1476

[Muscle invasive bladder cance ...... ors of adjuvant chemotherapy].

@en

P2093

A Heidenreich

http://www.w3.org/2001/XMLSchema#string

A K Thissen

http://www.w3.org/2001/XMLSchema#string

D Pfister

http://www.w3.org/2001/XMLSchema#string

P2860

Action of DNA repair endonuclease ERCC1/XPF in living cells.

Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.

Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting.

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

P304

1233-1241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00120-013-3311-5

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23975218

http://www.w3.org/2001/XMLSchema#string